Coronavirus
Japan’s Kowa says ivermectin showed ‘antiviral effect’ against omicron in research
Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against omicron and other variants of coronavirus in joint non-clinical research.
For more coronavirus news, visit our dedicated page.
Kowa did not provide further details. The firm has been working with Kitasato University, a medical university in Tokyo.
Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy
The drug is not approved for treatment of COVID-19 in Japan and the US Federal Drug Administration has repeatedly warned against its use.
Read more:
Russia sees over 100,000 daily COVID-19 cases for first time
Canada truckers head for Ottawa to protest vaccine mandate
COVID-19 cases plateauing in parts of India but omicron still surges
Also Read
-
Canada truckers head for Ottawa to protest vaccine mandate
Hundreds of Canadian truckers converged on Ottawa Friday for a major demonstration against vaccine mandates to cross the Canada-US border. Coming from ... World News -
COVID-19 cases plateauing in parts of India but omicron still surges
Indian health officials said Thursday there were signs of COVID-19 infections plateauing in some parts of the country but cautioned that cases were ... World News -
Russia sees over 100,000 daily COVID-19 cases for first time
Russia reported more than 100,000 daily coronavirus cases for the first time on Saturday as the country weathers a surge of infections driven by the ... World News
